BEMO:2000115 · BEMO metric v1.0.0

Diagnostic Odds Ratio

A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of diagnostic odds ratio.

CandidateTemplateComputableGenericTemplateDefined
Scientific pillar
External Validity, Biomarkers, and Clinical Evidence
Source category
Diagnostic and Prognostic Evidence
Output scale
RatioScale
Source maturity
Established

Scientific meaning

What it measures

Assesses diagnostic odds ratio using evidence appropriate to diagnostic and prognostic evidence, distinguishing random uncertainty from systematic error.

Why it matters

Material weakness in diagnostic odds ratio can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.

Measurement criteria

Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.

Typical methods of assessment

Two-by-two tables; binomial confidence intervals; hierarchical diagnostic meta-analysis; threshold and prevalence analyses.

Computation profile

value = numerator / denominator; the null value is typically 1 where scientifically applicable
Computation mode
QuantitativeRatioComputation
Readiness
TemplateComputable
Formula status
GenericTemplateDefined
Method family
ratio estimation
Output datatype
xsd:decimal
Unit or scale
Ratio scale; null typically 1
Numeric range
0 to +∞
Directionality
ContextDependentDirection

Required inputs

  • numerator
  • denominator
  • operational_definition
  • assessment_context

Optional inputs

  • confidence_level
  • stratum

Machine-readable expression

{
  "language": "BEMO-Expression-JSON",
  "operator": "divide",
  "arguments": [
    "numerator",
    "denominator"
  ],
  "constraints": [
    "denominator != 0"
  ],
  "null_value": 1
}

Computation policies

Aggregation
Not specified in source; must be defined and versioned before composite use.
Normalization
None by default; any normalization must be justified, versioned, and validated.
Missing data
Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material.
Uncertainty required
Yes
Uncertainty method
Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable.
Confidence interval required
Yes
Threshold policy
Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction.
Decision thresholds
No universal threshold declared
Quality control
Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable.
Calibration
Not generally required unless converted to a probability or score.

Applicability and validation

Evidence object
Result / experiment / study / body of evidence, as applicable
Evidence level
Result / experiment / study / body of evidence, as applicable
Study types
Diagnostic accuracy, screening, prognostic-factor, and prediction-model studies
Domain
Diagnostic and Prognostic Evidence
Required data sources
Context-specific; use source references, registered studies, primary data, and authoritative biomedical resources as applicable.
Validation status
Source maturity: Established; BEMO computation profile requires independent validation.
Benchmark
A representative, versioned benchmark set is required before production use.
Reference standard
Use an independent reference standard when one exists; document expert-adjudicated alternatives.
External validation required
Yes

Interpretation safeguards

Common misinterpretations

Treating diagnostic odds ratio as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.

Limitations

Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.

Dependency status

Not yet curated. Closely related metrics are represented; causal or computational dependencies require expert curation.

Source provenance

Source workbook
Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx
Source worksheet
Biomedical Evidence Metrics
Source row
122
Source record SHA-256
a903f03627bce43e756f3c1d10c27c552a53bce0346a40196ea1cd72afe63de0
Definition source
Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 122; see source_references

Scientific references (4)

  1. https://pubmed.ncbi.nlm.nih.gov/22007046/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
  2. https://www.equator-network.org/reporting-guidelines/stard/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
  3. https://www.tripod-statement.org/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
  4. https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package

Governance and FAIR status

Lifecycle
Candidate
Approval
Draft
Owner
BEMO Project
Curator
Unassigned
Reviewer
Unassigned
License
Pending owner approval; CC BY 4.0 recommended for OBO compatibility.
Findable
Provisional: stable local ID assigned; public namespace registration pending.
Accessible
Provisional: package is distributable; permanent public release location pending.
Interoperable
Yes: OWL 2, RDF, SKOS, SHACL, JSON-LD, CSV, and OBO-style identifiers.
Reusable
Provisional: rich metadata supplied; open-license owner approval pending.
Governance note
Candidate term pending scientific, ontology-engineering, and computation-method review.
Editor note
Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use.